Patents, Legal Monopolies, and the High Prices for Drugs
![Audio Mises Wire](https://cdn.mises.org/styles/responsive_4_3_650w/s3/static-page/img/AudioMisesWire_750x516_20180223.jpg.webp?itok=-YVs9bGp 650w,https://cdn.mises.org/styles/responsive_4_3_870w/s3/static-page/img/AudioMisesWire_750x516_20180223.jpg.webp?itok=Ry3vrlrf 870w,https://cdn.mises.org/styles/responsive_4_3_1090w/s3/static-page/img/AudioMisesWire_750x516_20180223.jpg.webp?itok=df3M-3lK 1090w,https://cdn.mises.org/styles/responsive_4_3_1310w/s3/static-page/img/AudioMisesWire_750x516_20180223.jpg.webp?itok=paTFGbVB 1310w,https://cdn.mises.org/styles/responsive_4_3_1530w/s3/static-page/img/AudioMisesWire_750x516_20180223.jpg.webp?itok=eIMm0OdX 1530w)
While government officials and politicians denounce high drug prices, they have created monopoly privileges for drug firms, thus ensuring higher-than-competitive prices for pharmaceuticals.
Original Article: “Patents, Legal Monopolies, and the High Prices for Drugs“
This Audio Mises Wire is generously sponsored by Christopher Condon. Narrated by Michael Stack.